Ms. Kristen Millado MD

Recommended Articles

• Lymphoma, the Persistence of Inspirational Women, and the Power of Language

  Each year, Leukemia and Blood Cancer New Zealand (LBC) sponsors their Blood Cancer Patient Forum. They invite speakers to bring them news about such topics as treatment advances and management of cancer from a fully developed psycho-social perspective. Essentially, they dish up good old-fashioned...

• New Diagnostic Tool Approved for Lymphoma

  A new diagnostic tool has been approved by the U.S. Food and Drug Administration (FDA) to help researchers identify leukemia and lymphoma cells by using a technique known as flow cytometry. A flow cytometry test for non-Hodgkin’s lymphoma (NHL) can help determine whether normal or abnormal DNA is...

• Mr. T's Lessons on Life and Lymphoma

  There are several things that Mr. T is known for, including his career as a WWF wrestler and his role as B.A. Baracus in the hit series ‘The A-Team’. To this day, he continues to remain a fun and stylish icon of the 80s. Nevertheless, Mr. T is not only known for his appearances on television,...

• Little Boy Tugs at Heartstrings of Entire Community: Be the Match!

  Danny Feltwell, a young six-year-old boy, was diagnosed with T-cell lymphoblastic lymphoma when he was just two years old. After undergoing countless procedures and just four months from being considered fully cured, Danny relapsed and had to be re-hospitalized. The doctors found that a large tumor...

• Life Lessons After Multiple Misdiagnoses of Lymphoma

  28-year-old Jessica DeCristofaro had been coughing persistently and she was told by her doctor that it was a result of allergies. She even took medication for her supposed allergies over the course of two years. When the medication failed to improve her persistent cough, another doctor diagnosed her...

• Treatment Update for Hodgkin Lymphoma

  Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...